Evidence map›Paper›PMID 29758928›Full record

ArticleCancer biomarkers : section A of Disease markers2018

MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.

Wei Ding, Hongbo Tan, Xuemei Li, Yue Zhang, Fang Fang, Yuanyuan Tian, Jin Li, Xinghua Pan

Abstract read
In one paragraph

Article in Cancer biomarkers : section A of Disease markers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. The role of PI3K/AKT signaling pathway in gallbladder carcinoma.American journal of translational research · 2022
    Review
  4. Article
  5. Article
  6. Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Wei DingDepartment of Clinical Laboratory, Kunming General Hospital, Chinese People's Liberation Army, Kunming 650032, Yunnan, China.
Hongbo TanDepartment of Orthopedics, Kunming General Hospital of Chinese People's Liberation Army, Kunming 650032, Yunnan, China.
Xuemei LiDepartment of Clinical Laboratory, Kunming General Hospital, Chinese People's Liberation Army, Kunming 650032, Yunnan, China.
Yue ZhangDepartment of Clinical Laboratory, Kunming General Hospital, Chinese People's Liberation Army, Kunming 650032, Yunnan, China.
Fang FangCollege of Medicine, Yunnan Economic Management College, Kunming 650106, Yunnan, China.
Yuanyuan TianDepartment of Clinical Laboratory, Kunming General Hospital, Chinese People's Liberation Army, Kunming 650032, Yunnan, China.
Jin LiDepartment of Clinical Laboratory, Kunming General Hospital, Chinese People's Liberation Army, Kunming 650032, Yunnan, China.
Xinghua PanStem Cell Engineering Laboratory of Yunnan Province, Kunming General Hospital, Chinese People's Liberation Army, Kunming 650032, Yunnan, China.
Kunming General Hospital of Chengdu Military Command · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundsMicroRNAs (miRNAs) are some RNA molecules that negatively regulate gene expression by binding to the 3'-untranslated region (3'-UTR) of target mRNA molecules. The aim of the study is to investigate the clinical role and functional effects of microRNA-493 (miR-493) in human hepatocellular carcinoma (HCC).

methodsExpression of miR-493 in 58 cases of HCC tissues and adjacent normal tissues was determined by using quantitative real-time PCR (qRT-PCR) analyses. In vitro, cell proliferation and invasion capacity was evaluated by CCK8 assay and trans-well invasion assay. Luciferase reporter assay, western blot and qRT-PCR were used to detect the association between miR-493 expression and zinc finger protein X-linked (ZFX) in HCC.

resultsExpression of miR-493 was significantly downregulated in HCC tissues compared to adjacent normal tissues. Lower miR-493 expression associated with tumor size, vascular invasion and poor overall survival (OS) and disease free survival (DFS) time of HCC patients. In vitro, transfection of miR-493 mimic in HCC cells inhibited cell proliferation and invasion abilities. However, transfection of miR-493 inhibitor in HCC cells had promoting effects. Luciferase reporter assay, qRT-PCR and western blot analysis demonstrated that miR-493 targeting 3'-untranslated region (3'-UTR) of ZFX and overexpression of miR-493 inhibited its expression. Moreover, enforced ZFX expression rescued the effects of miR-493 mimic on cell proliferation and invasion.

conclusionMiR-493 functioned as tumor suppressor in HCC cells by regulating ZFX expression. Thus, miR-493 may provide potential value for HCC treatment.

Indexed as

Gene Expression Regulation, Neoplastic3' Untranslated RegionsAdultAgedBiomarkers, TumorCarcinoma, HepatocellularCell Line, TumorCell MovementCell ProliferationFemaleGenes, ReporterHumansKruppel-Like Transcription FactorsLiver NeoplasmsMaleMicroRNAs3' Untranslated RegionsBiomarkers, TumorKruppel-Like Transcription FactorsMicroRNAsMIRN493 microRNA, humanzinc finger protein, X-linkedcell invasioncell proliferationMicroRNAsmiR-493ZFX

Identifiers

PMID29758928
PMCPMC13078471
OpenAlexW2799283425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.